 PHILADELPHIA, Aug. 05, 2022 GLOBE NEWSWIRE -- Passage Bio, Inc. NASDAQ: PASG, a clinical-stage genetic medicines company focused on developing transformative therapies for central nervous system CNS disorders, today announced that Simona King, chief financial officer of Passage Bio, will participate in a virtual panel discussion at the upcoming 2022 Wedbush PacGrow Healthcare Virtual Conference being held from August 9-10, 2022. 